Text Size

Cardiovascular Mortality Associated With Abnormal Calcium Metabolism

This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00018395
First received: July 3, 2001
Last updated: January 20, 2009
Last verified: December 2004
History of Changes
  Purpose

The purpose of this cohort study is to estimate the risk of cardiovascular mortality associated with abnormal calcium metabolism


Condition
Cardiovascular Disease
Kidney Disease

Study Type: Observational
Official Title: Cardiovascular Mortality Associated With Abnormal Calcium Metabolism

Resource links provided by NLM:

MedlinePlus related topics: Calcium
U.S. FDA Resources

Further study details as provided by Department of Veterans Affairs:

Study Start Date: August 1997
Estimated Study Completion Date: June 2002
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

All ESRD patients who indicated dialysis in 1990-1993

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00018395

Locations
United States, Washington
VA Puget Sound Health Care System
Seattle, Washington, United States, 98108
Sponsors and Collaborators
Department of Veterans Affairs
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00018395     History of Changes
Other Study ID Numbers: CADE-AI
Study First Received: July 3, 2001
Last Updated: January 20, 2009
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Calcium Metabolism

Additional relevant MeSH terms:
Cardiovascular Diseases
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on May 22, 2013